View attachment 93545
The indemnity clause protects the company (in this case Pfizer) from any financial liability in case of legal disputes. | OpIndia News
www.opindia.com
Not just indemnity, Pfizer wants disputes over vaccine supply under jurisdiction of US courts only, Indian govt in dilemma
The report stated that there are chances that the government may accept the indemnity clause, but the biggest hurdle is shifting the legal jurisdiction from India to the United States. The official quoted by Economic Times said that such a move will not be accepted by the Parliament.
fizer demands indemnity, won’t transfer technology for local production
Last month, Pfizer had informed that it had no plans to start production in the country. The pharmaceutical company said that it was not in talks with Indian authorities regarding production or technology transfer. As such, Pfizer jabs, if used in India, would be imported from its manufacturing sites in Europe and the United States. This would probably result in higher price of the vaccine in India, due to shipping costs and higher cost of manufacturing in the US and Europe compared to India.